US FDA Solicits Comments On Barriers To Innovative Trial Design Implementation

In admitting problems, the FDA creates a docket for comments and will convene a public workshop in the spring on why the clinical trial innovation is not more widespread.

breaking barriers — The docket on barriers to implementing clinical trial innovations is expected to open later this month. • Source: Shutterstock

Sponsors soon have a chance to advise the US Food and Drug Administration on the barriers and facilitators to implementing innovative clinical trial designs.

The agency has more than a dozen programs aimed at fostering various ideas that could improve the clinical trial system,...